Thirty-day hospital revisits after prostate brachytherapy: who is at risk?

Background: Transperineal prostate brachytherapy is a common outpatient procedure for the treatment of prostate cancer. Whereas long-term morbidity and toxicities are widely published, rates of short-term complications leading to hospital revisits have not been well described. Materials and methods:...

Full description

Bibliographic Details
Main Authors: Belinda Li, Eric J. Kirshenbaum, Robert H. Blackwell, William S. Gange, Jennifer Saluk, Matthew A.C. Zapf, Anai N. Kothari, Robert C. Flanigan, Gopal N. Gupta
Format: Article
Language:English
Published: Elsevier 2019-06-01
Series:Prostate International
Online Access:http://www.sciencedirect.com/science/article/pii/S2287888218300096